Cotización Impact Biomedical - IBO

Herramientas de nivel profesional para inversores individuales.

Premium

Último Precio

2.99

Postura de Compra

Postura de Venta

Volume Operado de la Acción

79,055

2.50 Rango del Día 2.99

1.22 Rango de 52 semanas 3.20

Precio Anterior

2.51

Precio de Apertura

2.51

Hora

100

2.9899

Última hora de negociación

Volumen promedio (3 m)

97,054

Volumen financiero

US$ 224,948

Precio Promedio Ponderado

2.8455

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease

HOUSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE: IBO), is thrilled to announce a significant milestone in its innovative Linebacker™ technology platform. The Canadian...

Form 8-K - Current report

Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates

HOUSTON, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative...

Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue

HOUSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (“IBO”) is pleased to announce that the US Patent and Trademark Office has issued U.S. Patent No. 11,985,973 entitled “Insect...

Impact BioMedical Inc. Introduces Leadership Team to Drive Innovation and Growth

NEW YORK, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting unique healthcare...

Form 8-K - Current report

Impact BioMedical Inc. Announces the Closing of its Initial Public Offering

NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness, today announced...

Impact BioMedical Inc. Announces Pricing of Initial Public Offering

NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness today announced the...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0.19	6.78571428571	2.8	3.2	2.49	55912	2.78003816	CS
4	1.54	106.206896552	1.45	3.2	1.22	63903	2.25473935	CS
12	-0.01	-0.333333333333	3	3.2	1.22	97054	2.225476	CS
26	-0.01	-0.333333333333	3	3.2	1.22	97054	2.225476	CS
52	-0.01	-0.333333333333	3	3.2	1.22	97054	2.225476	CS
156	-0.01	-0.333333333333	3	3.2	1.22	97054	2.225476	CS
260	-0.01	-0.333333333333	3	3.2	1.22	97054	2.225476	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
ARENArena Group Holdings Inc	US$ 1.7467 (206.44%)	92.56M
TMQTrilogy Metals Inc	US$ 1.255 (34.00%)	3.7M
IBOImpact Biomedical Inc	US$ 2.9899 (19.12%)	79.06k
NCLNorthann Corp	US$ 0.2721 (16.88%)	22.41M
LABDDirexion Daily S&P Biotech Bear 3X Shares	US$ 7.08 (16.07%)	35.99M
MINFT Limited	US$ 3.30 (-66.67%)	862.94k
KAPAKairos Pharma Ltd	US$ 1.56 (-24.11%)	273.56k
UAVSAgEagle Aerial Systems Inc	US$ 2.88 (-19.55%)	4.65M
TPETTrio Petroleum Corp	US$ 1.5811 (-18.67%)	719.05k
PHGEBiomX Inc	US$ 0.62 (-17.33%)	75.43k
SOXLDirexion Daily Semiconductor Bull 3X Shares	US$ 26.66 (-9.93%)	112.57M
ARENArena Group Holdings Inc	US$ 1.7467 (206.44%)	91.1M
IAUXi 80 Gold Corp	US$ 0.349072 (-10.84%)	76.6M
FOXOFOXO Technologies Inc	US$ 0.6695 (-0.07%)	75.19M
SPYSPDR S&P 500	US$ 585.75 (-1.28%)	74.29M